IO Biotech, Inc. Soared
Mon, Apr 06, 2026 at 07:22 PM
IO Biotech, Inc. (IOBT:NASDAQ) rocketted at $0.05, representing a gain of 48.6%. On Mon, Apr 06, 2026, IOBT:NASDAQ hit a New 2-Week Intraday Low of $0.03. The stock appeared on our News Catalysts scanner on Sun, Apr 05, 2026 at 10:56 PM in the 'BIOTECH' category. From Mon, Mar 23, 2026, the stock recorded 22.22% Up Days and 30.00% Green Days
The stock spiked on Wed, Oct 22, 2025 at $1.23 with a volume of 7M+.
About IO Biotech, Inc. (IOBT:NASDAQ)
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform.
Top 10 Gainers:
- Xiao-I Corporation (AIXI:NASDAQ), 515%
- F45 Training Holdings Inc. (FXLV:NYSE), 370.59%
- Profusa Inc. (PFSA:NASDAQ), 144.06%
- Moolec Science SA (MLEC:NASDAQ), 64.6%
- Maxeon Solar Technologies, Ltd. (MAXN:NASDAQ), 54.99%
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 53.66%
- IO Biotech, Inc. (IOBT:NASDAQ), 48.61%
- XWELL, Inc. (XWEL:NASDAQ), 42.06%
- ClearSign Technologies Corporation (CLIR:NASDAQ), 41.34%
- Jeffs' Brands Ltd (JFBR:NASDAQ), 40%